Therefore, a large number of CAR T clinical trials have shown that high serum IL-6 levels are associated with cytokine release syndrome (CRS), and IL-6 is a monitoring indicator in the clinical diagnosis and treatment of CRS (65). The gene discussed is IL6; the disease is congenital rubella syndrome.